Cover Image

Depression, anxiety and stress among metastatic breast cancer patients on chemotherapy in China

Abstract Objective This study aimed to assess the level of depression, anxiety and stress among metastatic breast cancer (MBC) patients undergoing chemotherapy (CT) in Beijing, China. Methods A cross-sectional study was conducted on 176 MBC women receiving CT, selected by purposive sampling. Data we...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi-Qiang Guo (Author), Qing-Mei Ju (Author), Miaoning You (Author), Yang Liu (Author), Azlina Yusuf (Author), Lean Keng Soon (Author)
Format:	Book
Published:	BMC, 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Breast awareness mobile apps for health education and promotion for breast cancer
by: Azlina Yusuf, et al.
Published: (2022)

Sequential Metastatic Breast Cancer Chemotherapy:Should the Median be the Message?
by: Su Yon eJung, et al.
Published: (2013)

Malaysian nurses' knowledge and attitudes regarding BRCA genetic testing
by: Kien Ting Liu, et al.
Published: (2021)

Anxiety and coping in women with breast cancer in chemotherapy
by: Araceli Vicente da Silva, et al.

Anxiety and depression symptoms among ovarian cancer patients in China: a cross-sectional study†
by: Chen Jing, et al.
Published: (2021)

Jadomycins: A potential chemotherapy for multi‐drug resistant metastatic breast cancer
by: Esther P. Bonitto, et al.
Published: (2021)

Atezolizumab Plus Chemotherapy vs. Chemotherapy in Advanced or Metastatic Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis
by: Xiaoyan Liu, et al.
Published: (2021)

The Regulatory Roles of Long-non-Coding RNAs in Chemotherapy-Resistant Metastatic Breast Cancer
by: Saeid Ghorbian, et al.
Published: (2020)

THE EFFECT OF ASSERTIVE COMMUNITY TREATMENT TOWARDS ANXIETY AND DEPRESSION ON BREAST CANCER CLIENT
by: Andikawati Fitriasari, et al.
Published: (2019)

Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer
by: Quan Liang, et al.
Published: (2016)

Combination chemotherapy in the treatment of breast cancer patients with metastatic brain involvement and a poor prognosis
by: D. R. Naskhletashvili, et al.
Published: (2014)

Mediating effects of depression on anxiety and leisure constraints in patients with breast cancer
by: Hsiu-Mei Huang, et al.
Published: (2019)

The Effect of Fatigue on Anxiety, Depression, and Sleep Quality in Patients Undergoing Chemotherapy
by: Duygu Akbas Uysal, Pinar Yel, Yasemin Yildirim and Ozlem Ozdemir
Published: (2023)

The Effect of Fatigue on Anxiety, Depression, and Sleep Quality in Patients Undergoing Chemotherapy
by: Duygu Akbas Uysal, Pinar Yel, Yasemin Yildirim and Ozlem Ozdemir
Published: (2023)

Toripalimab plus chemotherapy in the treatment of metastatic triple-negative breast cancer: a cost-effectiveness analysis
by: Hongfu Cai, et al.
Published: (2024)

Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy
by: Adriana J. Wong, et al.
Published: (2022)

Relationships among Malnutrition, Depression and Quality of Life in Patients with Gynecologic Cancer receiving Chemotherapy
by: Ju Hee Nho, et al.
Published: (2014)

Women with breast cancer taking chemotherapy: depression symptoms and treatment adherence
by: Bianca Fresche de Souza, et al.
Published: (2014)

Metastatic tuberculous abscess and papulonecrotic tuberculid developing during chemotherapy in a post-surgical case of carcinoma of breast
by: Priyanka K Kanoje
Published: (2024)

Cost-effectiveness of sacituzumab govitecan versus chemotherapy in patients with relapsed or refractory metastatic triple-negative breast cancer
by: Jiao Xie, et al.
Published: (2023)

A study of anxiety and depression in benign breast disease
by: Vivek Srivastava, et al.
Published: (2020)

First-line sintilimab plus chemotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A cost-effectiveness analysis from China
by: Jian Shen, et al.
Published: (2022)

Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis
by: Hong-Chen Qu, et al.
Published: (2020)

Cost-effectiveness analysis of first-line sintilimab plus chemotherapy vs. chemotherapy alone for unresectable advanced or metastatic gastric or gastroesophageal junction cancer in China
by: Zuojuan Xiang, et al.
Published: (2024)

Unsupported off-label chemotherapy in metastatic colon cancer
by: de Souza Jonas A, et al.
Published: (2012)

Cost-effectiveness analysis of sugemalimab vs. placebo, in combination with chemotherapy, for treatment of first-line metastatic NSCLC in China
by: Wei Li, et al.
Published: (2022)

Prevalence and Determinants of Anxiety and Depression Among Healthcare Workers in Liaoning Province, China
by: Lu J, et al.
Published: (2024)

Anxiety Levels of Breast Cancer Patients Undergoing Chemotherapy During the Covid-19 Pandemic
by: Fadillah Fadillah, et al.
Published: (2023)

Economic evaluation of tislelizumab versus chemotherapy as second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
by: Fenghao Shi, et al.
Published: (2022)

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy
by: Vera-Llonch Montserrat, et al.
Published: (2011)

From chemotherapy to oncoviruses - modern methods of treatment in metastatic melanoma
by: Hanna H. Drobek, et al.
Published: (2017)

Effect of Slow Stroke Back Massage on Anxiety of Older Women with Breast Cancer Undergoing Chemotherapy
by: Massoumeh Basiri, et al.
Published: (2016)

Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
by: Zhou C, et al.
Published: (2023)

Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
by: Yanhong Liu, et al.
Published: (2024)

Factors Related to Resilience, Anxiety/Depression, and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy in Japan
by: Saori Tamura
Published: (2021)

Drug treatment for metastatic breast cancer
by: E. V. Artamonova
Published: (2014)

CAPECITABINE AND IRINOTECAN AS FIRST- LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2010)

Factors associated with the sleep disturbances of people with breast cancer during chemotherapy in China: A cross‐sectional study
by: Wenjuan Zhu, et al.
Published: (2023)

Correlations of social isolation and anxiety and depression symptoms among patients with breast cancer of Heilongjiang province in China: The mediating role of social support
by: Bingshuo Liu, et al.
Published: (2021)

The Effects of Anlotinib Combined with Chemotherapy following Progression on Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive Metastatic Breast Cancer
by: Ting Xu, et al.
Published: (2024)